About Strella Biotech
Strella Biotech is a company based in Philadelphia (United States) founded in 2018.. Strella Biotech has raised $11.32 million across 4 funding rounds from investors including Union Labs, Catapult Ventures and Yamaha Motor Ventures. The company has 12 employees as of December 31, 2021. Strella Biotech offers products and services including Store, Ripen, Sequence, and Monitor. Strella Biotech operates in a competitive market with competitors including Allergy Amulet, ClariFruit, SensoGenic, Crystal Diagnostics and Dots, among others.
- Headquarter Philadelphia, United States
- Employees 12 as on 31 Dec, 2021
-
Sectors
TechnologyAgriculture
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Strella Biotechnology, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$11.32 M (USD)
in 4 rounds
-
Latest Funding Round
$5.6 M (USD), Debt – Conventional
Feb 21, 2024
-
Investors
Union Labs
& 11 more
-
Employee Count
12
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Strella Biotech
Strella Biotech offers a comprehensive portfolio of products and services, including Store, Ripen, Sequence, and Monitor. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Predicts produce maturity to reduce waste in storage
Automates processes for fruit and vegetable ripening
Optimizes produce shipout to minimize shrink
Provides real-time monitoring of produce supply chain conditions
Unlock access to complete
Funding Insights of Strella Biotech
Strella Biotech has successfully raised a total of $11.32M across 4 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $5.6 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Debt – Conventional — $5.6M
- First Round First Round
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2024 | Amount | Debt – Conventional - Strella Biotech | Valuation |
investors |
|
| Jun, 2022 | Amount | Series A - Strella Biotech | Valuation | Millennium Technology Value Partners | |
| Apr, 2020 | Amount | Seed - Strella Biotech | Valuation | Yamaha Motor Ventures , Catapult Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Strella Biotech
Strella Biotech has secured backing from 12 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Union Labs, Catapult Ventures and Yamaha Motor Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund investing in tech sectors
|
Founded Year | Domain | Location | |
|
Investment solutions are provided by Catapult Ventures for growth.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Strella Biotech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Strella Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Strella Biotech Comparisons
Competitors of Strella Biotech
Strella Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Allergy Amulet, ClariFruit, SensoGenic, Crystal Diagnostics and Dots, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Portable food allergen sensors are offered via an online platform.
|
|
| domain | founded_year | HQ Location |
Developer of app-based quality control software for fruits and vegetables
|
|
| domain | founded_year | HQ Location |
Diagnostics biosensors for food allergens are provided by SensoGenic.
|
|
| domain | founded_year | HQ Location |
Patented biosensors for detecting pathogens in food produce are developed.
|
|
| domain | founded_year | HQ Location |
Mobile casual and puzzle games are developed by Dots.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Strella Biotech
Frequently Asked Questions about Strella Biotech
When was Strella Biotech founded?
Strella Biotech was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Where is Strella Biotech located?
Strella Biotech is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Is Strella Biotech a funded company?
Strella Biotech is a funded company, having raised a total of $11.32M across 4 funding rounds to date. The company's 1st funding round was a Seed of $3.32M, raised on Apr 14, 2020.
How many employees does Strella Biotech have?
As of Dec 31, 2021, the latest employee count at Strella Biotech is 12.
What does Strella Biotech do?
Strella Biotech is a manufacturer of gas chromatography biosensors for sensing the ripeness of fruits. It can be installed in controlled atmosphere storage rooms to monitor fruits as they ripen, supporting packers and distributors in identifying the location of their ripest and readiest fruits. It claims to minimize the spoilage and quality downgrade cost and helps to reduce food waste. It has won multiple awards and competitions including awards at the third annual Innovation Open competition.
Who are the top competitors of Strella Biotech?
Strella Biotech's top competitors include Dots, Allergy Amulet and ClariFruit.
What products or services does Strella Biotech offer?
Strella Biotech offers Store, Ripen, Sequence, and Monitor.
Who are Strella Biotech's investors?
Strella Biotech has 12 investors. Key investors include Union Labs, Catapult Ventures, Yamaha Motor Ventures, Rich Products Ventures, and Google Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.